QuartataWeb 1.0

23 known interactions (drugs) of input target (FCGR1A): High affinity immunoglobulin gamma Fc receptor I

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter
1	Approved; Investigational	BiotechDrug	DB00087	Alemtuzumab	NA
2	Approved; Investigational; Withdrawn	BiotechDrug	DB06607	Catumaxomab	NA
3	Approved	BiotechDrug	DB00002	Cetuximab	NA
4	Approved; Investigational	BiotechDrug	DB11767	Sarilumab	NA
5	Approved; Investigational	SmallMoleculeDrug	DB00992	Methyl aminolevulinate	COC(=O)CCC(=O)CN
6	Approved; Investigational	BiotechDrug	DB00028	Immune Globulin Human	NA
7	Approved; Investigational; Withdrawn	BiotechDrug	DB00092	Alefacept	NA
8	Approved; Investigational	BiotechDrug	DB00108	Natalizumab	NA
9	Approved; Investigational	BiotechDrug	DB00074	Basiliximab	NA
10	Approved; Investigational	BiotechDrug	DB00095	Efalizumab	NA
11	Approved; Investigational	BiotechDrug	DB00112	Bevacizumab	NA
12	Approved; Investigational	BiotechDrug	DB00081	Tositumomab	NA
13	Approved; Investigational	BiotechDrug	DB00005	Etanercept	NA
14	Approved; Investigational	BiotechDrug	DB00056	Gemtuzumab ozogamicin	NA
15	Approved	BiotechDrug	DB00073	Rituximab	NA
16	Approved; Investigational	BiotechDrug	DB00078	Ibritumomab tiuxetan	NA
17	Approved	BiotechDrug	DB00051	Adalimumab	NA
18	Investigational; Withdrawn	BiotechDrug	DB00111	Daclizumab	NA
19	Approved	BiotechDrug	DB00054	Abciximab	NA
20	Approved; Investigational	BiotechDrug	DB00072	Trastuzumab	NA
21	Approved; Investigational	BiotechDrug	DB00075	Muromonab	NA
22	Approved; Investigational	BiotechDrug	DB00110	Palivizumab	NA
23	Approved; Investigational	SmallMoleculeDrug	DB00707	Porfimer sodium	NA

20 predicted interactions (drugs) of input target (FCGR1A): High affinity immunoglobulin gamma Fc receptor I

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Confidence score
1	Approved; Investigational	BiotechDrug	DB12023	Benralizumab	NA	46.5%
2	Approved	BiotechDrug	DB00098	Antithymocyte immunoglobulin (rabbit)	NA	43.1%
3	Approved; Investigational	SmallMoleculeDrug	DB01593	Zinc	[Zn]	40.3%
4	Approved; Investigational	BiotechDrug	DB09228	Conestat alfa	NA	36.1%
5	Experimental	SmallMoleculeDrug	DB02371	2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid	OCC(CO)(CO)NCCS(O)(=O)=O	32.4%
6	Approved	BiotechDrug	DB06404	Human C1-esterase inhibitor	NA	31.8%
7	Approved; Investigational	BiotechDrug	DB00004	Denileukin diftitox	NA	22.7%
8	Approved; Experimental	SmallMoleculeDrug	DB03017	Lauric Acid	CCCCCCCCCCCC(O)=O	21.0%
9	Approved	BiotechDrug	DB00041	Aldesleukin	NA	20.6%
10	Experimental	SmallMoleculeDrug	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O	19.9%
11	Approved; Investigational	BiotechDrug	DB11988	Ocrelizumab	NA	19.4%
12	Approved; Investigational	SmallMoleculeDrug	DB09462	Glycerin	OCC(O)CO	18.4%
13	Approved	BiotechDrug	DB06273	Tocilizumab	NA	18.2%
14	Approved; Withdrawn	SmallMoleculeDrug	DB09336	Technetium Tc-99m nofetumomab merpentan	NA	17.7%
15	Approved	SmallMoleculeDrug	DB11348	Calcium Phosphate	[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O	17.0%
16	Approved; Investigational	SmallMoleculeDrug	DB06151	Acetylcysteine	CC(=O)N[C@@H](CS)C(O)=O	16.9%
17	Experimental	SmallMoleculeDrug	DB03461	2'-Monophosphoadenosine 5'-Diphosphoribose	[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O	16.5%
18	Approved; Investigational	SmallMoleculeDrug	DB09130	Copper	[Cu]	16.3%
19	Approved; Investigational; Nutraceutical	SmallMoleculeDrug	DB00114	Pyridoxal Phosphate	CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O	16.2%
20	Approved; Nutraceutical	SmallMoleculeDrug	DB01373	Calcium	[Ca]	16.1%